Associations between Fluorescent Oxidation Products (FlOPs) level and change in asthma outcomes

M. Andrianjafimasy (Villejuif , France), Z. Akiki (Fanar, Lebanon), F. Zerimech (Lille, France), N. Le Moual (Villejuif, France), V. Siroux (La Tronche, France), O. Dumas (Villejuif, France), R. Matran (Lille, France), R. Nadif (Villejuif, France)

Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Session: Asthma and allergy in adults and children and their biomarkers
Session type: Poster Discussion
Number: 3909
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Andrianjafimasy (Villejuif , France), Z. Akiki (Fanar, Lebanon), F. Zerimech (Lille, France), N. Le Moual (Villejuif, France), V. Siroux (La Tronche, France), O. Dumas (Villejuif, France), R. Matran (Lille, France), R. Nadif (Villejuif, France). Associations between Fluorescent Oxidation Products (FlOPs) level and change in asthma outcomes. 3909

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Effects of Pulmonary Rehabilitation (PR) on Exercise Capacity (EC) and Quality of Life (QOL) in Indian Patients with Severe COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Comparison of different GC-IMS-devices for measurement of volatile biomarkers (VOC)
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Aspects of the placenta status in women with asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Time trends in asthma: Changes of prevalence from 1990 to 2010 in Italy. Preliminary results from the screening stage of the Genes Environment Interaction in Respiratory Diseases (GEIRD) study
Source: Annual Congress 2010 - Highlights of longitudinal, geographical and time trend studies of asthma and COPD
Year: 2010

Routine clinical use of Electronic Monitoring Devices (EMD) to measure inhaler adherence in children with Difficult Asthma (DA)
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


Weighted Gene Co-expression Network Analysis of blood paediatric samples from the U-BIOPRED study identifies oxidative stress association with asthma severity
Source: International Congress 2018 – New developments in paediatric asthma
Year: 2018



Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Influence of psychological characteristics of patients for asthma control
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


The Electronic Asthma Management System (eAMS) improves primary care asthma management
Source: Eur Respir J, 53 (4) 1802241; 10.1183/13993003.02241-2018
Year: 2019



Association of COPD and Asthma COPD Overlap (ACO) with World Trade Center (WTC) occupational exposure intensity
Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases
Year: 2021


Correlation among functional respiratory parameters and disease control in asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Association of candidate genes with FeNO in asthma: preliminary results from the Gene Environment Interactions in Respiratory Diseases (GEIRD) study.
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020


Exhaled fungal microbiome in asthma: Possible association with severity and control
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Human rhinovirus (HRV) induced changes in mild asthma: Time course of clinical and inflammatory biomarker changes
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Predictors of a decreasing frequency of asthma symptoms. Results from the Disease Management Program (DMP) Bronchial Asthma in the North Rhine region in Germany.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Performance characteristics of an ECL immunoassay for the quantitation of serum periostin
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016